^Recent^News:

Visit us at
Deutscher Schmerzkongress

in Mannheim

(06-08th Oct 2011)

^{Opinions from our customers:}

Dr. G. Weiss (PASCOE pharmazeutische Praeparate GmbH):

"We cooperate very well since many years and learned to appreciate VivaCell as a reliable and competent co-operation partner in pre-clinical research. Therefore we are looking forward to continue our successful partnership."

Our recent Publications in 2011 range as follows:

2011

Pseudoephedrine inhibits T-cell activation by targeting NF-?B, NFAT and AP-1 signaling pathways.

Fiebich BL, Collado JA, Stratz C, Valina C, Hochholzer W, Muñoz E, Bellido LM.

Immunopharmacol Immunotoxicol. 2011 Jun 2

Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics?

Straube A, Aicher B, Fiebich BL, Haag G.

BMC Neurol. 2011 Mar 31;11:43. Review.

Minocycline reduces prostaglandin E synthase expression and 8-isoprostane formation in LPS-activated primary rat microglia.

Silva Bastos LF, Pinheiro de Oliveira AC, Magnus Schlachetzki JC, Fiebich BL.

Immunopharmacol Immunotoxicol. 2011 Sep;33(3):576-80. Epub 2011 Jan 12.

Pharmacological studies in an herbal drug combination of St. John's Wort (Hypericum perforatum) and passion flower (Passiflora incarnata): in vitro and in vivo evidence of synergy between Hypericum and Passiflora in antidepressant pharmacological models.

Fiebich BL, Knörle R, Appel K, Kammler T, Weiss G.

Fitoterapia. 2011 Apr;82(3):474-80. Epub 2010 Dec 24.